SEARCH BY
| Category | Company |
|---|---|
| Founded | 1948 |
| Sector | Life Science |
| Employees | 11,400 |
Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 14 |
| Sector: Medical Products M&A | 1 of 6 |
| Type: Add-on Acquisition M&A Deals | 2 of 13 |
| State: California M&A | 2 of 8 |
| Country: United States M&A | 2 of 14 |
| Year: 2006 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-11-20 |
Oculex Pharmaceuticals
Sunnyvale, California, United States Oculex Pharmaceuticals, Inc. is an Ophthalmic drug delivery company. |
Buy | $230M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-09-19 |
Esprit Pharma
Irvine, California, United States Esprit is a U.S.-based pharmaceutical company focused on the genitourinary (GU) and women’s healthcare markets. Esprit currently markets SANCTURA® (trospium chloride) for the treatment of overactive bladder (OAB), as well as ESTRASORB® (estradiol topical emulsion) for vaso-motor symptoms associated with menopause. In addition, Esprit controls marketing rights to the recently approved SANCTURA® XR, a novel, once-daily formulation of trospium chloride that has demonstrated outstanding clinical results in terms of efficacy and tolerability in the treatment of OAB. |
Buy | - |
